Artificial intelligence can help researchers propose peptide structures and sequences worth testing. Its value lies in narrowing a difficult search, not in certifying that a generated molecule is a medicine. The distinction between prediction and experimental evidence remains central.

A primary RFpeptides study used deep-learning methods to design macrocyclic peptide binders and reported experimental structural validation for selected designs. This shows a research capability within a defined task, not automatic clinical success. Deep learning design of protein binding macrocycles

A binding result is one milestone

A candidate that binds a target still needs to be evaluated for selectivity, stability, exposure and safety. The intended biological effect must also occur in an appropriate system. A favorable computational score cannot answer all of those questions.

Another primary study applied generative AI to peptide antibiotic optimization. Its measured antimicrobial results illustrate why computational proposals and laboratory testing should be connected in an iterative process. They do not show that every generated peptide will work in people. Generative AI for peptide antibiotic optimization

Evaluate the validation rather than the label

When reading an AI discovery claim, ask which candidates were tested, how they were selected and what baseline method was used. Check whether evaluation data were genuinely independent of training data. A comparison with an unrealistically weak baseline can exaggerate the apparent advantage.

Also distinguish a successful research demonstration from a reproducible platform. A model may perform well for a particular scaffold or target while struggling with other chemistry. Published code, data and experimental details help others assess that scope.

AXON treats AI as a tool for generating and prioritizing hypotheses. Human trials and regulatory review remain separate requirements for a therapeutic claim. The most useful headline is therefore not that AI has “found a cure,” but that a defined method produced candidates that passed specific experimental tests and now require the next stage of evaluation.